Related Experiment Video
Updated: Jun 11, 2026
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Aspirin Use Following the Arterial Switch Operation in the United States: Variability, Trends, and Perioperative
Edo K S Bedzra1, Muhammad Faateh2, Hosam F Ahmed2
1Children's Mercy Hospital, Kansas City, MO, USA.
Insights
Aspirin use after arterial switch operation (ASO) is increasing but varies widely. This study found aspirin use was associated with lower in-hospital mortality without increasing bleeding risks in ASO patients.
Area of Science:
- Cardiology
- Pediatric Surgery
- Pharmacology
Background:
- Aspirin's role in preventing coronary thromboembolism after arterial switch operation (ASO) is not well-defined.
- Current use of aspirin post-ASO is inconsistent, with unknown benefits and outcomes.
Purpose of the Study:
- To analyze trends and outcomes associated with aspirin use in patients following ASO.
- To evaluate variations in aspirin prescription patterns across centers.
Main Methods:
- Retrospective analysis of 6,350 ASO cases from the Pediatric Health Information System.
- Comparison of outcomes between patients who received aspirin post-ASO and those who did not.
- Statistical adjustment for potential confounding factors.
Main Results:
- Aspirin use increased from 17% in 2004 to 39% in 2022, with more high-volume centers adopting its use.
- The aspirin group had significantly lower in-hospital mortality (0.9% vs 3.4%, P < .001).
- No significant increase in reoperation for bleeding or need for extracorporeal membrane oxygenation was observed in the aspirin group.
Conclusions:
- Significant variation exists in aspirin use following ASO, with an upward trend observed.
- Aspirin administration post-ASO appears safe, not increasing major adverse events like bleeding.
- Further prospective studies are warranted to confirm the safety and efficacy of aspirin in ASO patients.
Abstract:
BackgroundAspirin has the potential of offering coronary arterial protection from thromboembolism for patients following the arterial switch operation (ASO) but is used inconsistently and the benefits are unknown. We sought to discern trends and outcomes associated with the use of aspirin following the ASO.MethodsPatients undergoing the ASO were identified from the Pediatric Health Information System and divided into two groups: those who received aspirin post-ASO versus the nonaspirin group to evaluate trends, variations, and outcomes.ResultsA total of 6,350 ASO cases were identified (44 centers) of which 1,751 (27.6%) were in the aspirin group. Aspirin was started after a median postoperative duration of four days (interquartile range: 1-7). The aspirin group was more likely to have coronary anomalies (221/1,751[12.6%] vs 358/4,599 [7.8%], P < .001) and transposition of the great arteries + double outlet right ventricle (109/1,751 [6.2%] vs 313/4,599 [6.8%], P = .01). Aspirin use increased from 17% of case in 2004 to 39% in 2022. The number of centers using aspirin for ≥50% of their ASO patients increased from 2004 to 2008: 4 centers to 2019 to 2022: 15 centers (out of 32 centers with consistent participation) with a greater proportion of high-volume centers using aspirin. Overall, the aspirin group had lower in-hospital mortality (16/1,751 [0.9%] vs 155/4,599 [3.4%], P < .001) and similar rates of reoperation for bleeding (59/1,751 [3.4%] vs 203/4,599 [4.4%], P = .06) and postoperative extracorporeal membrane oxygenation (70/1,755 [4%] vs 195/4,599 [4.2%], P = .67). After adjusting for confounders, the mortality difference remained significant: odds ratio: 0.22 (95%CI: 0.10-0.47), P < .001.ConclusionConsiderable variation exists in the use of aspirin post-ASO with an overall increasing trend in aspirin use. In this study, the use of aspirin did not result in an increase in postoperative bleeding or other major adverse events. Prospective studies are needed to confirm the safety and benefits of aspirin.
More Related Videos
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
06:04Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
